Concepedia

Publication | Open Access

A phase 2 study of pegylated interferon α‐2b (PEG‐Intron®) in children with diffuse intrinsic pontine glioma

DOIFull Paper Access

47

Citations

23

References

2011

Year

Katherine E. Warren, Robyn Bent, Pamela L. Wolters, Alisa J. Prager, Ryan Hanson, Roger J. Packer, Joanna H. Shih, Kevin Camphausen
Cancer

Abstract

Although low-dose PEG-Intron(®) therapy did not significantly improve 2-year survival in children with DIPG compared with an historic control population, it did delay the time to progression.

References

YearCitations

Page 1